Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer
ABSTRACT Background The convergence of nanotechnology and immunotherapy has ushered in a transformative era in cancer treatment, offering new strategies to overcome pharmacokinetic limitations and immune evasion associated with conventional therapies. While immunotherapy, spanning checkpoint inhibitors, adoptive cell transfer, and cancer vaccines, has ...
Nima Javanmehr +4 more
wiley +1 more source
Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity. [PDF]
Dabour MS +7 more
europepmc +1 more source
Anti-PD-1 immune checkpoint inhibitor-induced cardiotoxicity is associated with dysfunctional metabolism, muscle wasting and autophagy. [PDF]
Tichy L, Parry TL.
europepmc +1 more source
L-Methionine attenuates methotrexate-induced cardiotoxicity by modulating oxidative stress, inflammation, and dyslipidemia in rats. [PDF]
Abdel-Wahab WM, Daifalla NS, Essawy AE.
europepmc +1 more source
BACH2 alleviates immune checkpoint inhibitors-induced cardiac pyroptosis via transcriptionally promoting GRSF1. [PDF]
Cao M +9 more
europepmc +1 more source
Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity. [PDF]
Singh G +12 more
europepmc +1 more source
Polyphenol-rich Cucurbita formulation mitigates doxorubicin-induced cardiotoxicity in rats: biochemical, histological, and molecular docking insights. [PDF]
Iftikhar N +11 more
europepmc +1 more source
Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity
Mitochondrial DNA (mtDNA) is a potent agonist of the innate immune system; however, the exact immunostimulatory features of mtDNA and the kinetics of mtDNA detection by cytosolic nucleic acid sensors remain poorly defined.
Carl W Tong +2 more
exaly +2 more sources
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity
Fasting strategies are under active clinical investigation in patients receiving chemotherapy. Prior murine studies suggest that alternate-day fasting may attenuate doxorubicin cardiotoxicity and stimulate nuclear translocation of transcription factor EB
Mualla Ozcan, Zhen Guo, Carmen Bergom
exaly +2 more sources

